北米眼科レーザー市場 – 業界動向と2030年までの予測

北米眼科レーザー市場の分析と洞察

北米の眼科用レーザー市場は、2023年から2030年の予測期間に市場成長が見込まれています。データブリッジマーケットリサーチは、市場は2023年から2030年の予測期間に6.8%のCAGRで成長し、2022年の9億3,891万米ドルから2030年までに15億8,340万米ドルに達すると分析しています。

この眼科用レーザー市場レポートでは、最近の新しい開発、貿易規制、輸出入分析、生産分析、バリュー チェーンの最適化、市場シェア、国内および現地の市場プレーヤーの影響、新たな収益源の観点から見た機会の分析、市場規制の変更、戦略的市場成長分析、市場規模、カテゴリ市場の成長、アプリケーションのニッチと優位性、製品の承認、製品の発売、地理的拡張、市場における技術革新などの詳細が提供されます。眼科用レーザー市場に関する詳細情報を取得するには、アナリスト ブリーフについて Data Bridge Market Research にお問い合わせください。当社のチームは、市場の成長を達成するために情報に基づいた市場決定を行うお手伝いをします。

市場の定義

Ophthalmology lasers are specialized medical devices that emit focused beams of light to treat various eye conditions. These lasers are commonly used in ophthalmology to perform various procedures, such as treating vision disorders, correcting refractive errors, and managing various eye diseases. The devices gained increased importance and adoption due to the high prevalence of several ophthalmic diseases, such as glaucoma, cataract, and other vision-related issues.

North America Ophthalmology Lasers Market Dynamics

 This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:

Drivers

• Increasing incidences of chronic and communicable eye diseases

The field of ophthalmology has seen a rise in the incidence of both chronic and communicable eye diseases in recent years. Some of the major factors contributing to this trend include a growing North America population, an aging population, increased urbanization, changing lifestyles, and increased exposure to environmental pollutants. One of the most common chronic eye diseases is Age-Related Macular Degeneration (AMD). AMD is a leading cause of blindness in people over the age of 60 and is caused by damage to the macula, a small part of the retina responsible for central vision. The prevalence of AMD is expected to increase with an aging North America population. Another chronic eye disease that is becoming more prevalent is glaucoma. Glaucoma is a group of eye diseases that cause damage to the optic nerve and can lead to blindness. It is often asymptomatic until it reaches an advanced stage, making regular eye exams crucial for early detection and treatment.

In March 2023, according to an article by Indian Express, North America, glaucoma is the second leading cause of blindness after cataracts. It is estimated to cause blindness in 4.5 million people worldwide. Despite this, glaucoma is largely undiagnosed, with more than 90 percent of untreated cases. Thus, increasing incidences of chronic and communicable eye diseases are expected to drive the market's growth.

• Increased consumer awareness for laser treatments

Consumer awareness of laser therapies has increased, which has benefited the market for ophthalmic lasers North America. Several factors have contributed to this trend, including advancements in technology, increased access to information, and greater emphasis on patient education. One of the main drivers of increased consumer awareness is the development of new laser systems that offer improved precision, reduced recovery times, and better outcomes. These systems have been shown to be effective in treating a range of eye conditions, from refractive errors to more complex retinal disorders. Patients are increasingly interested in these treatments and are seeking out ophthalmologists who are trained to use them. Another factor contributing to increased awareness is the availability of information about ophthalmology lasers. Patients can easily access information online about the different types of laser treatments available, their benefits, and potential risks. This has helped to demystify laser treatments and make them more accessible to a wider range of patients which is expected to drive the market's growth.

• Increasing adoption of outpatient procedures

The field of ophthalmology has seen significant advancements in recent years with the advent of laser technology. With the increasing adoption of outpatient procedures, the North America ophthalmology lasers market presents a significant opportunity for growth. Outpatient procedures are medical procedures that do not require an overnight stay in a hospital. These procedures can be performed in a medical office, ambulatory surgery center, or outpatient clinic. Thus, the increasing adoption of outpatient procedures is expected to drive the market's growth.

Opportunities

• Technological advancements in ophthalmology

Technological advancements in the field of ophthalmology have revolutionized the diagnosis, treatment, and management of various eye diseases and conditions. These advancements have created significant opportunities in the North America ophthalmology lasers market, with the potential to improve patient outcomes, increase efficiency, and drive growth in the industry. One of the most significant technological advancements in ophthalmology has been the development of femtosecond lasers. These lasers are used for precision surgeries and can create incisions that are more precise and predictable than those created by traditional surgical tools. This technology has revolutionized procedures such as photocoagulation lasers, Selective Laser Trabeculoplasty (SLT), allowing for faster recovery times and better visual outcomes, which is expected to provide a lucrative opportunity for the market's growth.

Restraints/Challenges

• Lack of skilled professionals

Ophthalmology lasers are used in various procedures, including refractive surgeries, cataract surgeries, and glaucoma treatment. However, the effective use of these lasers requires skilled professionals who are proficient in handling them. The lack of such professionals can lead to errors, complications, and adverse outcomes, which can harm patients and damage the industry's reputation.

The main reason for the shortage of skilled professionals is the complexity of the equipment and the procedures involved. Ophthalmology lasers require specialized knowledge and expertise, and the training required to become proficient in using them can be time-consuming and expensive. In addition, the procedures themselves are often intricate and require a high level of skill and precision

Hence, a lack of skilled professionals will impede the growth rate of the ophthalmology lasers market. Additionally, stringent rules and regulations will further challenge the market in the forecast period.

Recent Development

• In November 2022, Alcon, the North America leader in eye care dedicated to helping people see brilliantly, announced that it had completed its acquisition of Aerie Pharmaceuticals, Inc. This transaction helps bolster Alcon's presence in the ophthalmic pharmaceutical space with its growing portfolio of commercial products and development pipeline.
• In March 2023, Bausch + Lomb Corporation and Novaliq GmbH announced that the American Journal of Ophthalmology had published results from MOJAVE, the second pivotal Phase 3 trial for NOV03 (perfluorohexyloctane). NOV03 is being investigated to treat the signs and symptoms of Dry Eye Disease (DED) associated with Meibomian Gland Dysfunction (MGD). Results from the first pivotal Phase 3 trial, GOBI, were published earlier this year in the American Journal of Ophthalmology.

North America Ophthalmology Lasers Market Scope

The North America ophthalmology lasers market is segmented into product, type, application, gases, and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

Product

• Femtosecond Lasers
• Excimer Lasers
• Nd: YAG Lasers
• Diode Lasers
• Others

On the basis of product, the market is segmented into femtosecond lasers, excimer lasers, Nd: YAG lasers, diode lasers, and others.

Type

• Photodisruption Lasers
• Selective Laser Trabeculoplasty (SLT)
• Photocoagulation Lasers

On the basis of type, the market is segmented into photodisruption lasers, selective laser trabeculoplasty (SLT), and photocoagulation lasers.

Application

• Diagnostics
• Therapeutics

On the basis of application, the market is segmented into diagnostics and therapeutics.

Gases

• Noble gas
• Halogen gas
• Buffer gas
• Others

On the basis of gases, the market is segmented into noble gas, halogen gas, buffer gas, and others.

End User

• Hospitals
• Clinics
• Others

エンドユーザーに基づいて、市場は病院、診療所、その他に分類されます。

北米眼科用レーザー市場の地域分析/洞察     

北米の眼科用レーザー市場が分析され、上記のように国、製品、タイプ、用途、ガス、エンドユーザー別に市場規模の洞察と傾向が提供されます。

北米の眼科用レーザー市場に含まれる国は、米国、カナダ、メキシコです。

この地域における眼科疾患の有病率の高さと急速な研究開発により、米国は北米の眼科レーザー市場を支配すると予想されています。

レポートの国別セクションでは、市場の現在および将来の傾向に影響を与える個別の市場影響要因と市場規制の変更も提供しています。新規および交換販売、国の人口統計、疾病疫学、輸出入関税などのデータ ポイントは、個々の国の市場シナリオを予測するために使用される主要な指標の一部です。さらに、国別データの予測分析を提供する際には、北米ブランドの存在と可用性、地元および国内ブランドとの激しい競争により直面する課題、販売チャネルの影響が考慮されています。

競争環境と北米眼科用レーザー市場シェア分析

北米眼科用レーザー市場の競争状況は、競合他社による詳細を提供します。含まれる詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、北米でのプレゼンス、生産拠点と施設、生産能力、会社の強みと弱み、製品の発売、製品の幅と広さ、アプリケーションの優位性などがあります。提供されている上記のデータ ポイントは、北米眼科用レーザー市場における会社の焦点にのみ関連しています。

北米の眼科用レーザー市場で事業を展開している主要企業としては、NIDEK CO., LTD.、Calmar Laser、LENSAR, INC.、OD-OS、Quantel Medical（Lumibird Medicalの子会社）、Alcon、Ziemer Ophthalmic Systems AG、LIGHTMED、Johnson & Johnson Inc.、Bausch & Lomb Incorporated、MEDA Co., Ltd.、Topcon、Lumenis Be Ltd.、IRIDEX Corporation、Zeissなどが挙げられます。

SKU-69951